New data compiled by industry shows lengthy timelines for access to new medicines that improve care standards in Ireland Two years in the reimbursement process is too […]
Delayed access to time-critical new medicines, the focus of an Oireachtas briefing session. Interrupting the continuous flow of new medicines due to lack of investment is […]
Contrary to popular belief, a general internet search and social media are some of the least likely sources that people would consider when it comes to […]
Scientific innovation has advanced significantly over the past number of years bringing new hope and therapies to patients around the globe. Unfortunately, as a result of […]
Amgen, MSD and Gilead feature in IPHA’s campaign that demonstrates the promise of science through animation style storytelling. Thursday, 14th September 2023 The Irish Pharmaceutical Healthcare […]